“…In CRS, a potential role for dysregulation of the ECM is suggested by pooling‐based genomewide association studies (p‐GWAS) identifying ECM genes (FBLN1, LAMB1, LAMA2) as top candidates 2,3. Further support for a potential role of the ECM in the pathogenesis of CRS is afforded by the demonstration of increased expression of periostin (POSTN), a component of the ECM, in CRS biopsy samples.…”
Demonstration of reduced levels in the expression of POSTN, an ECM gene, following resolution of disease, implicates POSTN, a potential pathogenesis indicator or biomarker of CRS disease activity and responsiveness to treatment.
“…In CRS, a potential role for dysregulation of the ECM is suggested by pooling‐based genomewide association studies (p‐GWAS) identifying ECM genes (FBLN1, LAMB1, LAMA2) as top candidates 2,3. Further support for a potential role of the ECM in the pathogenesis of CRS is afforded by the demonstration of increased expression of periostin (POSTN), a component of the ECM, in CRS biopsy samples.…”
Demonstration of reduced levels in the expression of POSTN, an ECM gene, following resolution of disease, implicates POSTN, a potential pathogenesis indicator or biomarker of CRS disease activity and responsiveness to treatment.
“…SPARC (secreted protein acidic and rich in cysteine), also known as osteonectin, belongs to the basic HLH factors. 17 We have previously described elevated SPARC expression patterns in gene expression profiles of primary epithelial cultures raised from CRS mucosal biopsies, 18 which prompted our current investigation. Our objective in this study was to evaluate the SPARC protein in serum as a biomarker of EMT activation in patients with CRS.…”
“…Evidence for a role in immune deficiency in CRS has already been suggested by studies of innate immunity in CRS by the documentation of reduced number of Toll‐like receptor 2 (TLR2) receptors in patients with CRS and a reduced function of TLR2 receptors in epithelial cells cultured from CRS subjects . Altered function of major histocompatibility complex class I (MHCI) molecules and/or of CD8 lymphocyte functions may also play a role.…”
Low CD8+ levels are often identified in CRS patients; however, these patients have disease remarkably similar to those with conventional CRS. This suggests that immune deficiency, whether systemic or locally mediated, is well tolerated and may be present in other forms in CRS. CRS patients with low CD8+ levels may possibly require antibacterial therapies as part of ongoing management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.